特纳综合征患者颌面部特征的临床意义

基础医学与临床 ›› 2020, Vol. 40 ›› Issue (2): 248-252.

特纳综合征患者颌面部特征的临床意义

梁思宇¹, 陈适², 王诗蕊¹, 潘周娴¹, 朱佳伟¹, 朱惠娟², 潘慧^2*

1.中国医学科学院北京协和医学院北京协和医院临床医学八年制, 北京 100730;
2.中国医学科学院北京协和医学院北京协和医院内分泌科卫生部内分泌重点实验室, 北京 100730

收稿日期:2019-04-01 修回日期:2019-09-04 出版日期:2020-02-05 发布日期:2020-02-05
通讯作者: ^*panhui20111111@163.com
基金资助:
北京协和医学院大学生创新训练计划(2018zlgc0647,2018zlgc0621);北京协和医学院青年教师培训项目(2014zlgc0721);北京协和医学院教学改革项目(2014zlgc0141)

Clinical value of maxillofacial characteristics in Turner syndrome patients

LIANG Si-yu¹, CHEN Shi², WANG Shi-rui¹, PAN Zhou-xian¹, ZHU Jia-wei¹, ZHU Hui-juan², PAN Hui^2*

1. Eight-year Program of Clinical Medicine;
2. Department of Endocrinology, Endocrine Key Laboratory of Ministry of Health, Peking Union Medical College Hospital, CAMS & PUMC, Beijing 100730, China

Received:2019-04-01 Revised:2019-09-04 Online:2020-02-05 Published:2020-02-05
Contact: ^*panhui20111111@163.com

摘要/Abstract

摘要： 特纳综合征患者具有特征性的颌面部异常,与多种疾病相关,包括传导性听力丧失、喂养困难、睡眠呼吸暂停和发声异常等。特纳综合征颌面部特征可以通过头影测量学进行定量研究,还可以利用颌面部特征进行产前诊断。这些颌面部异常可能与X染色体上影响第一咽弓发育的基因相关,如SHOX;还可能与X染色体上影响组蛋白修饰的基因相关,如HDAC8。长期生长激素治疗对特纳综合征患者颅面发育具有改善作用,对下颌支的影响最明显,然而生长激素治疗不能使颌面部异常完全正常化。因其诊断价值、相关疾病风险和治疗可能,特纳综合征患者的异常颌面部特征应该引起更多的关注。

关键词: 特纳综合征, 颌面部, 小颌, 缩颌, 高腭弓

Abstract: Turner syndrome has characteristic maxillofacial abnormalities associated with a variety of diseases, including conductive hearing loss, feeding difficulties, sleep apnea, and vocal abnormalities. The maxillofacial characters of Turner syndrome can be quantitatively studied by cephalometric study. Prenatal diagnosis can also be performed by maxillofacial abnormalities. These abnormalities may be related to genes affecting the development of the first pharyngeal arch on the X chromosome, such as SHOX; may also be associated with genes on the X chromosome that affect histone modifications, such as HDAC8. Long-term growth hormone therapy has an enhanced effect on craniofacial development in patients with Turner syndrome, and a significant improvement on mandibular growth. However, growth hormone therapy can not completely normalize maxillofacial abnormalities. Maxillofacial abnormalities in patients with Turner syndrome should draw more attention due to its diagnostic value, associated disease risk and treatable potential.

Key words: Turner syndrome, maxillofacial, micrognathia, retrognathia, high arched palate

中图分类号:

R725.8

梁思宇, 陈适, 王诗蕊, 潘周娴, 朱佳伟, 朱惠娟, 潘慧. 特纳综合征患者颌面部特征的临床意义[J]. 基础医学与临床, 2020, 40(2): 248-252.

LIANG Si-yu, CHEN Shi, WANG Shi-rui, PAN Zhou-xian, ZHU Jia-wei, ZHU Hui-juan, PAN Hui. Clinical value of maxillofacial characteristics in Turner syndrome patients[J]. Basic & Clinical Medicine, 2020, 40(2): 248-252.

参考文献

[1]Palmer CG, Reichmann A. Chromosomal and clinical findings in 110 females with Turner syndrome[J]. Hum Genet, 1976, 35:35-49.
[2]Sávendahl L, Davenport ML. Delayed diagnoses of Turner's syndrome: proposed guidelines for change[J]. J Pediatr, 2000, 137:455-459.
[3]Miguel-Neto J, Carvalho AB, Marques-de-Faria AP, et al. New approach to phenotypic variability and karyotype-phenotype correlation in Turner syndrome[J]. J Pediatr Endocrinol Metab, 2016, 29:475-479.
[4]Perkiomaki MR, Kyrkanides S, Niinimaa A, et al. The relationship of distinct craniofacial features between Turner syndrome females and their parents[J]. Eur J Orthod, 2005, 27:48-52.
[5]Rizell S, Barrenás ML, Andlin-Sobocki A, et al. 45,X/46,XX karyotype mitigates the aberrant craniofacial morphology in Turner syndrome[J]. Eur J Orthod, 2013, 35:467-474.
[6]Bergamaschi R, Bergonzoni C, Mazzanti L, et al. Hearing loss in Turner syndrome: results of a multicentric study[J]. J Endocrinol Invest, 2008, 31:779-783.
[7]Clement-Jones M, Schiller S, Rao E, et al. The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome[J]. Hum Mol Genet, 2000, 9:695-702.
[8]Ishiguro K, Kobayashi T, Kitamura N, et al. Relationship between severity of sleep-disordered breathing and craniofacial morphology in Japanese male patients[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2009, 107:343-349.
[9]Eklund M, Kotilainen J, Eválahti M, et al. Cephalometric analysis of pharyngeal airway space dimensions in Turner syndrome[J]. Eur J Orthod, 2012, 34:219-225.
[10]Grauer D, Cevidanes LS, Styner MA, et al. Pharyngeal airway volume and shape from cone-beam computed tomography: relationship to facial morphology[J]. Am J Orthod Dentofacial Orthop, 2009, 136:805-814.
[11]Andersson-Wallgren G, Ohlsson AC, Albertsson-Wikland K, et al. Growth promoting treatment normalizes speech frequency in Turner syndrome[J]. Laryngoscope, 2008, 118:1125-1130.
[12]Hoopmann M, Sonek J, Goldschmid D, et al. Maxillary length in euploid and aneuploid fetuses[J]. Arch Gynecol Obstet, 2017, 295:331-336.
[13]Abele H, Sonek J, Goldschmid D, et al. Sphenofrontal distance in euploid and aneuploid fetuses[J]. Ultrasound Obstet Gynecol, 2017, 50:187-191.
[14]Svanberg C, Norevall LI, Ekman B, et al. Cephalometric analysis of adults with Turner syndrome[J]. Swed Dent J, 2016, 40:33-41.
[15]Thilander B. Dentoalveolar development in subjects with normal occlusion: a longitudinal study between the ages of 5 and 31 years[J]. Eur J Orthod, 2009, 31:109-120.
[16]Rizell S, Barrenás ML, Andlin-Sobocki A, et al. Palatal height and dental arch dimensions in Turner syndrome karyotypes[J]. Eur J Orthod, 2013, 35:841-847.
[17]Ogata T, Muroya K, Sasaki G, et al. SHOX nullizygosity and haploinsufficiency in a Japanese family: implication for the development of Turner skeletal features[J]. J Clin Endocrinol Metab, 2002, 87:1390-1394.
[18]Zinn AR, Tonk VS, Chen Z, et al. Evidence for a Turner syndrome locus or loci at Xp11.2-p22.1[J]. Am J Hum Genet, 1998, 63:1757-1766.
[19]Harakalova M, van den Boogaard MJ, Sinke R, et al. X-exome sequencing identifies a HDAC8 variant in a large pedigree with X-linked intellectual disability, truncal obesity, gynaecomastia, hypogonadism and unusual face[J]. J Med Genet, 2012, 49:539-543.
[20]Barrenás M, Landin-Wilhelmsen K, Hanson C. Ear and hearing in relation to genotype and growth in Turner syndrome[J]. Hear Res, 2000, 144:21-28.
[21]Juloski J, Dumančić J, Sćepan I, et al. Growth hormone positive effects on craniofacial complex in Turner syndrome[J]. Arch Oral Biol, 2016, 71:10-15.
[22]Rongen-Westerlaken C, vd Born E, Prahl-Andersen B, et al. Effect of growth hormone treatment on craniofacial growth in Turner's syndrome[J]. Acta Paediatr, 1993, 82:364-368.
[23]Simmons KE. Growth hormone and craniofacial changes: preliminary data from studies in Turner's syndrome[J]. Pediatrics, 1999, 104:1021-1024.
[24]Juloski J, Glisic B , Scepan I, et al. Ontogenetic changes of craniofacial complex in Turner syndrome patients treated with growth hormone[J]. Clin Oral Investig, 2013, 17:1563-1571.
[25]Maranhão MV. Turner syndrome and anesthesia[J]. Rev Bras Anestesiol, 2008, 58:84-89.
[26]Aristizábal JF, Smit RM. Two-phase orthodontic treatment in a patient with turner syndrome: an unusual case of deep bite[J]. Cleft Palate Craniofac J, 2015, 52:e56-64